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The CAMCOG: A Useful Screening Instrument for
Dementia in Stroke Patients
Inge de Koning, MA; Fop van Kooten, MD; Diederik W.J. Dippel, MD, PhD;
Frans van Harskamp, MD; Diederick E. Grobbee, MD, PhD;
Cornelis Kluft, PhD; Peter J. Koudstaal, MD, PhD
Background and Purpose—Most mental screening tests focus on the detection of cognitive deficits compatible with
Alzheimer’s disease. Stroke patients who develop a dementia syndrome, however, constitute a more heterogeneous
group with both cortical and subcortical disturbances. We assessed the diagnostic accuracy of the CAMCOG (the
cognitive and self-contained part of the Cambridge Examination for Mental Disorders of the Elderly) and the
Mini-Mental State Examination (MMSE) for dementia in patients with a recent stroke.
Methods—In patients aged 55 and older who were admitted in the Rotterdam Stroke Databank, cognitive functioning was
assessed between 3 and 9 months after the most recent stroke. The “gold standard” diagnosis of dementia was
compatible with the criteria of the Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. The
CAMCOG and MMSE scores were obtained independent of the diagnostic procedure.
Results—Of 300 consecutive patients, 71 (23.7%) were demented. Sixteen severely demented patients could not be tested
and were excluded. The CAMCOG and MMSE scores were significantly related to dementia (both P,0.0001) in a
logistic regression model. Receiver operating characteristic analysis showed that the CAMCOG was a more accurate
screening instrument (area under the curve for CAMCOG, 0.95; for MMSE, 0.90). Two other clinical variables
independently improved the diagnostic accuracy of the MMSE and CAMCOG: patients with a left hemispheric lesion
had a lower (odds ratio, 0.3; 95% confidence interval, 0.1 to 0.7), and patients with hemorrhagic stroke had a greater
chance of being demented (odds ratio, 3; 95% confidence interval, 1 to 10). The effect of left hemispheric lesion as an
independent diagnostic factor could not be explained by selection or its association with aphasia alone.
Conclusions—The CAMCOG is a feasible instrument for use in patients with a recent transient ischemic attack or stroke.
It is a more accurate screening tool for dementia than the MMSE, especially when type and site of stroke are taken into
account. (Stroke. 1998;29:2080-2086.)
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In patients with a recent stroke, it is important to assesscognitive deficits in a quick and convenient but also
reliable and accurate way. In the past, several mental status
tests have been developed for this purpose: the Mini-Mental
State Examination (MMSE),1 Mental Status Questionnaire,2
Short Portable Mental Status Questionnaire,3 Cognitive Ca-
pacity Screening Examination,4 Neurobehavioral Cognitive
Status,5 and the Short Blessed Test.6 Although these tests do
not provide the same amount and type of information as a full
neuropsychological examination, they may be used for se-
lecting patients in whom such an extended neuropsycholog-
ical examination is necessary. Most brief cognitive screening
instruments have been developed for the detection of demen-
tia of the Alzheimer type and focus on orientation, memory,
and higher cortical functions such as aphasia, apraxia, and
agnosia. Aspects of cognitive functioning, such as slowing of
intellectual functioning, abstraction, retrieval and recognition,
and visuoperceptual abilities, are less well measured. Stroke
patients who develop dementia, however, may have deficits
in any cognitive domain. The dementia syndrome may be
classified as subcortical in some and cortical in others.
Previous studies in stroke populations7,8 also suggest that
brief mental status tests are relatively insensitive to specific
brain lesions or focal cognitive deficits. Cognitive screening
tasks predominantly contain verbally mediated items and
therefore tend to exaggerate the extent of cognitive deficits in
patients with left hemispheric lesions. Likewise, tests that
emphasize verbal capacities may underestimate the conse-
quences of right hemispheric lesions.9–11 The question is
whether these tests are valid tools in stroke patients.
The CAMCOG is the cognitive and self-contained part of
the Cambridge Examination for Mental Disorders of the
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Elderly (CAMDEX),12 a standardized instrument for the
diagnosis and grading of dementia. The CAMCOG consists
of 67 items with a maximum possible score of 107, and it can
be divided in several subscales: orientation, expressive and
comprehensive language, memory (remote, recent, and learn-
ing), attention, praxis, calculation, abstraction, and percep-
tion. All items of the MMSE are also incorporated into the
CAMCOG. Although the CAMCOG was also originally
designed to diagnose primary degenerative dementia, it has
an advantage over brief screening tests in that it covers a
broader range of cognitive functions in a relatively short
amount of time. It also detects mild cognitive deterioration
and has few ceiling effects.12 Studies of the CAMCOG
have focused on the utility and validity of the complete
CAMDEX.12–15 In most of these studies the CAMCOG cutoff
point of 79/80 suggested by Roth et al12 seemed satisfactory
for discriminating between normal subjects and demented
patients. Lindeboom et al16 reviewed some psychometric
properties of the CAMCOG and found that it was stable and
reliable and differentiated well between normal cognitive
functioning and mild cognitive impairment. So far, little is
known about the diagnostic value of the CAMCOG in a
stroke population. Somatic handicaps as well as cortical
disturbances such as aphasia or neglect may have a negative
influence on its accuracy.
In this study, we investigated the diagnostic value of the
CAMCOG as a screening instrument for poststroke dementia
in comparison with the MMSE. Furthermore, we assessed the
role of other clinical factors that could confound or modify
the relationship between the screening test results and the
presence of dementia.
Subjects and Methods
Subjects
Patients were recruited from the Rotterdam Stroke Databank, a
prospective registry of patients with a transient ischemic attack
(TIA), ischemic stroke, or primary intracerebral hemorrhage who
were admitted to the Department of Neurology of the University
Hospital Rotterdam. From March 1, 1993, until January 15, 1996, all
consecutive patients who met the criteria for enrollment in the Dutch
Vascular Factors in Dementia Study were entered.17 Patients had to
be 55 years or older and to have had a TIA with neurological signs
on examination, an ischemic stroke, or intracerebral hemorrhage.
Patients were excluded when a reliable assessment of dementia could
not be made because of aphasia (ie, a score of less than 3 on the
Aphasia Severity Rating Scale from the Boston Diagnostic Aphasia
Examination),18 severe sensory handicaps (eg, deafness or blind-
ness), persistent impairment in consciousness, severe psychiatric
symptoms, or insufficient command of the Dutch language. Addi-
tional exclusions were a TIA without neurological signs, concomi-
tant primary cerebral disorder, or severe comorbidity with a short life
expectancy. Informed consent was obtained from all patients or from
close relatives in case of impaired judgment in the patient.
Procedure
The clinical characteristics of the patients at baseline were assessed
shortly after admission to the hospital. We obtained detailed infor-
mation about cardiovascular risk factors, stroke characteristics, and
premorbid mental and physical status. In addition to a full neurolog-
ical examination, ancillary investigations consisted of standardized
blood tests, chest x-ray, CT scanning and/or MRI of the brain, duplex
scanning of the carotid arteries, and a cardiac analysis. Premorbid
cognitive functioning was established by an interview with a close
relative and the score on the Blessed Dementia Scale. Education was
categorized by the number of years of schooling completed. Between
3 and 9 months after stroke onset, cognitive functioning was assessed
by a neurologist, based on clinical observation, the information of a
close informant, and the score on the Blessed Dementia Scale. In
case of any suspicion of cognitive decline, patients were invited for
Figure 1. Diagram of the diagnostic pro-
cedure for dementia. ND indicates not
demented; D, demented.
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an extensive neuropsychological examination. We used the Aphasia
Severity Rating Scale of the Boston Diagnostic Aphasia Examination
to assess the presence and severity of aphasia. A score of 6 indicates
no aphasia, and scores of 5, 4, and 3 indicate mild to moderate
aphasia. A psychiatric examination was carried out in all demented
patients to assess the presence of depression.
The “gold standard” diagnosis of dementia was based on the
results of an extensive neuropsychological examination, clinical
presentation, and information from a close relative. Figure 1 repre-
sents the diagnostic procedure for dementia. The extensive neuro-
psychological examination was carried out in all patients in whom
there was any suspicion of dementia or cognitive decline. If patients
could not be tested because of cognitive deficits or if they refused to
cooperate further, the extensive neuropsychological evaluation was
not performed. In some patients only a limited number of tests could
be administered. The extensive neuropsychological examination
consisted of an intelligence test (either the shortened version of the
Groninger Intelligence Test,19 a Dutch intelligence test, or when this
could not be administered, Raven’s Colored Matrices,20 a nonverbal
intelligence test). The shortened form of the Boston Naming Test
(the Consortium to Establish a Registry for Alzheimer’s Disease
[CERAD])21 was used to examine word-finding difficulties. Memory
was evaluated with Word List Memory (CERAD)21 and the River-
mead Behavioral Memory Test.22 We used Digit Span forward and
backward (Wechsler Adult Intelligence Scale [WAIS])23 to assess the
span of immediate verbal recall and also as a measure for attentional
capacity. Parts of the Trail-Making Test24 and the Stroop color word
test25 were also used to examine attention. Scores on verbal fluency
(animals, occupations, letter B), Stroop color word test part III,25 and
Trail-Making Test B24 served as indicators for the level of executive
functioning. Proverbs and similarities (WAIS)23 provided a measure
for abstraction and verbal concept formation. Visuoconstructive
ability was examined by copying the drawing of a circle, diamond,
two overlapping rectangles, and a cube (CERAD).21 Visual percep-
tion and spatial orientation were examined by Judgment of Line
Orientation.26 Based on clinical presentation, information from a
close relative, the score on the Blessed dementia scale, and the
neuropsychological test results, a final judgment of cognitive func-
tioning was made by a diagnostic panel consisting of two neurolo-
gists, a neuropsychologist, and a trained physician. For the assess-
ment of dementia, the criteria of the Diagnostic and Statistical
Manual of Mental Disorders, Third Edition, Revised,27 were used.
Further subclassification of dementia took place according to the
research criteria of the NINDS-AIREN International Workshop.28
Independent of the diagnostic procedure, the MMSE and the
Geriatric Mental Status29 and the Dutch version of the cognitive and
self-contained part of the CAMDEX,30,31 the CAMCOG, were
administered in all patients.
Statistical Analysis
For the comparison of the clinical characteristics of the demented
and nondemented patients, Student’s t test and a x2 test were used
when appropriate. The relationship between clinical characteristics
and dementia was described by means of odds ratios (ORs) with a
95% confidence interval (CI). The ORs for the dichotomous vari-
ables were estimated by contingency table analysis, and for the
CAMCOG and MMSE by means of logistic regression. To deter-
mine the influence of other diagnostic information independently of
the MMSE or CAMCOG score, multiple logistic regression was
used. The diagnostic accuracy of the CAMCOG and the MMSE,
with and without adjustment for other diagnostic factors, was
compared by receiver operating characteristic (ROC) curves, by
measuring the area under the curve. The statistical significance of the
regression models was assessed by a standard likelihood ratio test;
the fit was assessed by means of the Hosmer-Lemeshow x2 test and
by plotting observed and expected numbers of patients by deciles of
the predicted probabilities. All statistical analyses were carried out
using Stata software.32
Results
From the 825 patients who were entered into the Rotterdam
Stroke Databank, 198 were younger than 55 years of age, 122
died within 3 months after stroke onset, 42 had a TIA without
any sign appearing during neurological examination, 41 had
severe aphasia, another 76 were excluded for various other
reasons (eg, moved out of the region, did not speak Dutch,
and had a short life expectancy because of other intracranial
pathology), and 46 did not give informed consent (Figure 2). Of
the remaining 300 patients who met the criteria for inclusion in
The Dutch Vascular Factors in Dementia Study, 16 were
excluded from the present study because the CAMCOG could
not be administered due to severe dementia. The clinical char-
acteristics of the 284 study patients are summarized in Table 1.
The mean age was approximately 70 years, and 40% were
female. One sixth of the patients had had a TIA, and a little more
than one tenth an intracerebral hemorrhage. Of the demented
patients in our study population, approximately one quarter were
diagnosed with possible Alzheimer’s disease with cerebrovas-
cular disease; the other demented patients were classified as
having possible or probable vascular dementia. Aphasia was
present in 7% of all patients. Demented patients scored signifi-
cantly lower (on average, 25 points) on the CAMCOG (95% CI,
22.1 to 27.9) than nondemented patients. Demented patients
were on average 4.8 years older (95% CI, 2.5 to 7.1), and they
Figure 2. Diagram of the process for selection of patients for
the present study.
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were more often female. They had on average 1.4 fewer years of
education than nondemented patients (95% CI, 0.5 to 2.3).
Neurological deficits, such as the presence of apraxia, neglect,
hemianopia, facial paralysis, and paresis of arm or leg, were
associated with dementia, but aphasia was not. Table 2 gives the
corresponding ORs with 95% CIs for each factor by itself. In our
study, each point increase in the CAMCOG score decreased the
odds of dementia by 0.83, and each point increase in the MMSE
score decreased the odds of dementia by 0.64. Although the
relative odds reduction per point is larger for the MMSE, the
CAMCOG is by far the better test, because the range of possible
scores is larger (30 versus 107). ROC analysis shows that the
CAMCOG was more accurate in screening for dementia than the
MMSE (area under the ROC curve: MMSE, 0.90, versus
CAMCOG, 0.95) (Figure 3). We could improve the predictions
by adding other diagnostic factors: patients with a left hemi-
spheric lesion had a 3 times lower risk of dementia, independent
of the CAMCOG or MMSE score, and patients with a hemor-
rhagic lesion had an approximately 3 times higher risk of
dementia independent of test score. In univariate analyses, TIA
was related to a reduced risk of dementia. In the multiple
regression model, however, TIA was not significantly related to
a reduced risk of dementia in our study population. Age, gender,
and education are known to influence screening test scores, but
they showed no significant relation to the presence of dementia
and the CAMCOG score in our study. After adjusting for site
and type of stroke, the area under the curve increased by
0.01 in both curves. The predictions based on the MMSE
were always less accurate than CAMCOG-based predic-
tions, even when they were adjusted for type and site of
stroke. The predictions based on the CAMCOG with
adjustment for the 2 diagnostic factors appeared to be the
best, as the area under the ROC curve was largest (0.96).
The CAMCOG had the best overall fit (Table 3). Figure 4
shows the relationship between the risk of dementia and
the CAMCOG score in our study, adjusted for type and site
of stroke. The additional diagnostic factors have a maxi-
mum effect in the middle range of the CAMCOG scores. In
our study approximately 45% of the patients have a
CAMCOG score between 55 and 87. For example, the
predicted probability of dementia in a patient with a
CAMCOG score of 75 would be 30% in our study. Taking
TABLE 1. Baseline Characteristics of the Study Population
Total Study Group,
n5284
Not Demented,
n5229
Demented,
n555
Age* 69.2 (8.1) 68.2 (8.0) 73.0 (7.3)‡
Years of education* 8.7 (3.1) 9.0 (3.0) 7.6 (2.9)§
Female sex† 114 (40) 84 (37) 30 (55)\
CAMCOG* 83.3 (14.1) 88.2 (8.7) 63.2 (14.1)‡
MMSE* 25.4 (4.3) 26.7 (2.7) 19.9 (5.2)‡
“Prestroke” Blessed score .0† 26 (10) 6 (3) 20 (37)‡
Type of stroke†
TIA 46 (16) 43 (19) 3 (5)
Ischemic infarction 203 (71) 164 (71) 39 (71)
Intracerebral hemorrhage 35 (12) 22 (10) 13 (24)§
Site of stroke†
Right hemisphere 133 (47) 104 (45) 29 (53)
Left hemisphere 116 (41) 100 (44) 16 (29)
Infratentorial 35 (12) 25 (11) 10 (18)
Dementia type†
Possible VaD 5 (9)
Probable VaD 35 (64)
Possible AD1CVD 15 (27)
Aphasia† 19 (7) 16 (7) 3 (5)
Apraxia† 9 (3) 3 (1) 6 (11)§
Neglect† 15 (5) 4 (2) 11 (20)‡
Hemianopia† 22 (8) 10 (4) 12 (22)‡
Facial paralysis† 54 (19) 36 (16) 18 (33)§
Any arm paresis† 69 (24) 49 (21) 20 (36)\
Any leg paresis† 64 (23) 44 (19) 20 (36)§
VaD indicates vascular dementia; AD1CVD, Alzheimer’s disease with cerebrovascular disease.
*Values are means with standard deviations in parentheses.
†Values are number of patients with (column) percentages in parentheses.
‡Demented patients significantly different from nondemented patients (P,0.001).
§Demented patients significantly different from nondemented patients (P,0.01).
\Demented patients significantly different from nondemented patients (P,0.05).
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into account that this patient had a left-sided ischemic
stroke would lower the probability of dementia to 10%,
whereas a patient with a right-sided hemorrhagic stroke
and the same CAMCOG score would be much more likely
to be demented (probability of 60%).
Discussion
We investigated the diagnostic accuracy of the CAMCOG in
patients with a recent stroke in a prospective study by
comparing the CAMCOG with a final gold standard judg-
ment of cognitive functioning. The CAMCOG was more
sensitive and specific than the MMSE as a screening instru-
ment for dementia in stroke patients. Despite its length and
multiplicity, the CAMCOG appeared well administrable in an
elderly stroke population. Of the 300 patients, the CAMCOG
could be administered in 95% of the patients and the MMSE
in 97%. The experience with the CAMCOG in stroke popu-
lations is limited. Kwa et al33 found that the CAMCOG was
administrable in 88% of an ischemic stroke population, which
also included patients younger than 55 years. Since their main
interest was in the extent to which the CAMCOG is feasible
in an ischemic stroke population, they included all aphasic
patients and allowed adaptations in administration, such as
the use of gestures. We excluded patients with a severe
aphasia because differentiation between dementia and severe
aphasia is very difficult, and sometimes impossible, even for
experienced neuropsychologists who use a large test battery.
Figure 3. Receiver operating characteristic curves to determine
the diagnostic accuracy of the CAMCOG and the MMSE.
TABLE 2. Relationship Between Clinical Characteristics and
the Presence of Dementia
Characteristic OR 95% CI
Univariate analysis
CAMCOG score 0.83 0.79–0.87*
MMSE score 0.64 0.57–0.72*
Age 1.08 1.04–1.12*
Female sex 2.1 1.1–3.7
Years of education 0.83 0.73–0.93
TIA 0.25 0.08–0.77
Left hemisphere 0.5 0.3–1.0
Intracerebral hemorrhage 2.9 1.4–6.2
Aphasia 0.8 0.2–2.6
Apraxia 9.7 2.6–36.8
Neglect 11.2 3.9–32.4
Arm paresis 2.1 1.1–3.9
Leg paresis 2.4 1.3–4.5
Hemianopia 6.1 2.5–14.7
Multiple regression model
CAMCOG score 0.83 0.79–0.87
Left hemispheric lesion 0.3 0.1–0.9
Intracerebral hemorrhage 3.1 1.0–9.7
MMSE score 0.63 0.56–0.71
Left hemispheric lesion 0.3 0.1–0.7
Intracerebral hemorrhage 2.6 1.0–7.4
*Estimated by logistic regression; odds ratios per unit increase.
TABLE 3. Observed and Predicted Number of Demented Patients, According to the 4 Logistic
Regression Models, by Quintiles of the Predicted Probabilities
CAMCOG*
P50.21
MMSE†
P50.02
CAMCOG Adjusted‡
P50.19
MMSE Adjusted§
P50.05
Observed Predicted Observed Predicted Observed Predicted Observed Predicted
0 0.4 1 1.5 0 0.3 0 1.0
1 1.4 2 4.7 0 0.7 0 2.3
0 2.8 1 2.4 1 2.6 6 3.2
12 9.2 18 10.7 13 8.7 15 11.9
42 41.2 33 35.7 41 42.7 34 36.7
Fit was assessed by means of the Hosmer-Lemeshow x2 test.
*O5e13.21(20.193C)
†O5e9.21(20.443M)
‡O5e13.51(20.193C)1(1.133H)1(21.183L)
§O5e9.81(20.463M)1(0.973H)1(21.33L), where O indicates odds of dementia; C, CAMCOG score; M, MMSE score; L,
presence (1) or absence (0) of left hemispheric lesion; and H, presence (1) or absence (0) of hemorrhagic stroke.
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The CAMCOG may be administrable in such patients, but the
score is meaningless because it remains unclear to what
extent the total score is determined by the presence of
dementia or by aphasia.
The finding that the CAMCOG is a more sensitive and
specific screening instrument than the MMSE in an elderly
stroke population is not surprising, as the CAMCOG contains
more items on memory, language, and construction and
allows a more differentiated judgment about these functions
than the MMSE. Furthermore, the CAMCOG comprises
items on more cognitive domains in comparison with the
MMSE, by adding subtests for abstraction, fluency, and
perceptual tasks. It is therefore a priori quite likely that the
CAMCOG is more sensitive and specific than the MMSE in
a heterogeneous group such as stroke patients. On the other
hand, the addition of items is, by itself, not enough to increase
sensitivity and specificity. Grace et al8 performed a study in
which the original MMSE was compared with a modified
version, the 3MS. This modified version contains the items of
the original MMSE that were given a different weight, and
extra items such as abstraction and fluency were added. In
that study, the 3MS and MMSE had a similar overall
classification accuracy, which was adequate for patients with
left hemispheric strokes and poor for patients with right-sided
strokes. In our study, the CAMCOG score seemed to over-
estimate the risk of dementia in patients with a left hemi-
spheric stroke compared to those with a right hemispheric
stroke, which may indicate that the CAMCOG tends to
overemphasize focal cognitive deficits in these patients.
Previous studies34–37 suggest that age and education level
are associated with dementia and also with performance on
the CAMCOG.16,38 In our study, age and education had no
additional diagnostic value in a multiple logistic regression
model. One obvious explanation is that these factors are
already accounted for in the CAMCOG score, as they are
associated with dementia alone. We found that apart from the
CAMCOG score, only type and site of stroke were useful in
predicting the probability of dementia 3 months after stroke.
Patients with an intracerebral hemorrhage had an approxi-
mately 3 times greater risk of dementia after stroke than
patients with a TIA or ischemic stroke, whereas patients with
a left hemispheric stroke had a 3 times lower risk than
patients with a right hemispheric stroke. The finding that
apraxia, mainly a consequence of left hemispheric lesions,
was strongly associated with the presence of dementia in an
univariate analysis seems to be incongruent with this finding.
The number of patients with apraxia, however, was small and
therefore may have had little effect on the total group of
patients with left hemispheric stroke.
Patients with left hemispheric stroke were less likely to be
demented 3 months after stroke even after adjustment for
other diagnostic factors, which is not in agreement with some
other studies39–41 which found that a left hemispheric stroke
increases the risk of cognitive impairment or dementia. There
are some explanations for our finding. First, we may have
overestimated the role of mild and moderate aphasia in
neuropsychological test scores and therefore underestimated
the extent of general cognitive decline. The proportion of
aphasic patients in our study, however, was equal for de-
mented and nondemented patients, and also when we in-
cluded the demented patients in whom a CAMCOG was not
administrable. Second, since patients with a severe aphasia
were excluded because this prevented a reliable assessment of
dementia, we excluded more massive left hemispheric strokes
as opposed to massive right hemispheric strokes. In our study,
however, patients with left hemispheric stroke did not differ
from those with right hemispheric stroke with respect to the
presence of hemianopia, facial paresis, or arm or leg paresis.
In conclusion, the CAMCOG is easily administered and is
an accurate screening tool for dementia in patients with a
recent stroke. Our study results suggest that the CAMCOG
has additional diagnostic value compared with the MMSE,
especially when type and site of stroke are taken into account.
A prospective study in a different but comparable stroke
population is needed to confirm our results.
Figure 4. Relationship between the risk of demen-
tia and the CAMCOG score, with adjustment for
type and site of stroke, determined by logistic
regression.
de Koning et al October 1998 2085
Acknowledgments
The Dutch Vascular Factors in Dementia study is supported by the
Netherlands program research on aging, NESTOR, funded by the
Ministry of Education, Cultural Affairs and Science and the Ministry
of Health, Welfare and Sports. The Rotterdam Stroke Databank is
supported by the Stichting Neurovasculair Onderzoek Rotterdam.
References
1. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical
method for grading the cognitive state of patients for the clinician.
J Psychiatr Res. 1975;12:189–198.
2. Kahn RL, Goldfarb AI, Pollack M, Peck A. Brief objective measures for
the determination of mental status in the aged. Am J Psychiatry. 1960;
117:326–329.
3. Pfeiffer E. A short portable mental status questionnaire for the assessment
of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975;23:
433–441.
4. Jacobs JW, Bernhard MR, Delgado A, Strain JJ. Screening for organic
mental syndromes in the medically ill. Ann Intern Med. 1977;86:40–46.
5. Kiernan RJ, Mueller J, Langston JW, Van Dyke C. The Neurobehavioral
Cognitive Status Examination: a brief but quantitative approach to cog-
nitive assessment. Ann Intern Med. 1987;107:481–485.
6. Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H.
Validation of a short Orientation-Memory-Concentration Test of cog-
nitive impairment. Am J Psychiatry. 1983;140:734–739.
7. Tsai L, Tsuang MT. The Mini-Mental State Test and computerized
tomography. Am J Psychiatry. 1979;136:436–438.
8. Grace J, Nadler JD, White DA, Guilmette TJ, Giuliano AJ, Monsch AU,
Snow MG. Folstein versus modified Mini-Mental State Examination in
geriatric stroke. Arch Neurol. 1995;52:477–484.
9. Dick JPR, Guiloff RJ, Stewart A, Blackstock J, Bielawska C, Paul EA,
Marsden CD. Mini-Mental State Examination in neurological patients.
J Neurol Neurosurg Psychiatry. 1984;47:496–499.
10. Nelson A, Fogel BS, Faust D. Bedside cognitive screening instruments: a
critical assessment. J Nerv Ment Dis. 1986;174:73–83.
11. Kupke T, Revis ES, Gantner AB. Hemispheric bias of the Mini-Mental
State Examination in elderly males. Clin Neuropsychol. 1993;7:210–214.
12. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S,
Goddard R. CAMDEX. A standardised instrument for the diagnosis of
mental disorder in the elderly with special reference to the early detection
of dementia. Br J Psychiatry. 1986;149:698–709.
13. O’Connor DW, Pollitt PA, Jones BJ, Hyde JB, Fellowes JL, Miller ND.
Continued clinical validation of dementia diagnosed in the community
using the Cambridge Mental Disorders of the Elderly Examination. Acta
Psychiatr Scand. 1991;83:41–45.
14. Hendrie HC, Hall KS, Brittain HM, Austrom MG, Farlow M, Parker J,
Kane M. The CAMDEX: a standardized instrument for the diagnosis of
mental disorder in the elderly: a replication with a US sample. J Am
Geriatr Soc. 1988;36:402–408.
15. Neri M, Roth M, Mountjoy CQ, Andermarcher E, Rubichi S, Spano A,
Salvioli G, Cipolli C. Validation of the full and short forms of the
CAMDEX interview for diagnosing dementia. Dementia. 1994;5:
257–265.
16. Lindeboom J, Ter Horst R, Hooyer C, Dinkgreve M, Jonker C. Some
psychometric properties of the CAMCOG. Psychol Med. 1993;23:
213–219.
17. Van Kooten F, Bots ML, Breteler MMB, Haverkate F, van Swieten JC,
Grobbee DE, Koudstaal PJ, Kluft C. The Dutch Vascular Factors in
Dementia Study: rationale and design. J Neurol. 1998;245:32–39.
18. Goodglass H, Kaplan E. The Assessment of Aphasia and Related Dis-
orders. 2nd ed. Philadelphia, Pa: Lea & Febiger; 1983.
19. Luteijn F, Vanderploeg FAE. Groninger Intelligentie Test Manual. Lisse,
Netherlands: Swets & Zeitlinger BV; 1983.
20. Raven JC. Guide to Using the Coloured Progressive Matrices. London,
UK: HK Lewis; 1965.
21. Morris JC, Heyman A, Mohs RC, Hughes JP, Van Belle G, Fillenbaum
G, Mellits ED, Clark C, and the CERAD Investigators. The Consortium
to Establish a Registry for Alzheimer’s Disease (CERAD), part I: clinical
and neuropsychological assessment of Alzheimer’s disease. Neurology.
1989;39:1159–1165.
22. Wilson BA, Cockburn J, Baddeley AD. Rivermead Behavioural Memory
Test. Reading, UK: Thames Valley Test Company; 1985.
23. Wechsler D, Stone C. Manual for the Wechsler Adult Intelligence Scale.
New York, NY: The Psychological Corporation; 1955. Dutch revision:
Stinissen J, Willems PJ, Coetsier P, Hulsman WLL. Handleiding bij de
Nederlandstalige bewerking van de WAIS. Lisse, Netherlands: Swets &
Zeitlinger BV; 1970.
24. Reitan RM. Validity of the Trail Making Test as an indication of organic
brain damage. Percept Mot Skills. 1958;8:271–276.
25. Hammes JGW. Stroop kleur-woord Test: Dutch manual. Lisse, Neth-
erlands: Swets & Zeitlinger BV; 1978.
26. Benton AL, Varney NR, Hamsher KD. Visuospatial judgment: a clinical
test. Arch Neurol. 1978;35:364–367.
27. American Psychiatric Association. Diagnostic and Statistical Manual of
Mental Disorders. 3rd ed, revised. Washington, DC: American Psy-
chiatric Association; 1987.
28. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia
JH, Amaducci L, Orgogozo J-M, Brun A, Hofman A, Moody DM, O’Brien
MD, Yamaguchi T, Grafman J, Drayer BP, Bennet DA, Fisher M, Ogata J,
Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell
MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A,
Scheinberg P. Vascular dementia: diagnostic criteria for research studies:
report of the NINDS-AIREN International Workshop. Neurology. 1993;43:
250–260.
29. Copeland JRM, Dewey ME, Griffiths-Jones HM. A computerized psy-
chiatric diagnostic system and case nomenclature for elderly subjects:
GMS and AGECAT. Psychol Med. 1986;16:89–99.
30. Derix MMA, Teunisse S, Hijdra A, Wens L, Hofstede AB, Walstra GJM,
Weinstein HC, Van Gool WA. CAMDEX-N: de Nederlandse versie
van de Cambridge Examination for Mental Disorders of the Elderly:
Dutch manual. Lisse, Netherlands: Swets & Zeitlinger BV; 1992.
31. Derix MMA, Hofstede AB, Teunisse S, Hijdra A, Walstra GJM,
Weinstein HC, Van Gool WA. CAMDEX-N: de Nederlandse versie van
de Cambridge Examination for Mental Disorders of the Elderly met
geautomatiseerde dataverwerking [CAMDEX-N: the Dutch version of
the CAMDEX with computerized data analysis]. Tijdschr Gerontol
Geriatr. 1991;22:143–150.
32. Stata Corporation. Stata Statistical Software, Release 5.0. College
Station, Tex: Stata Corporation; 1997.
33. Kwa VIH, Limburg M, Voogel AJ, Teunisse S, Derix MMA, Hijdra A.
Feasibility of cognitive screening of patients with ischaemic stroke using
the CAMCOG: a hospital-based study. J Neurol. 1996;243:405–409.
34. Breteler MMB, van den Ouweland FA, Grobbee DE, Hofman A. A
community-based study of dementia: the Rotterdam Elderly Study. Neu-
roepidemiology. 1992;11S1:23–28.
35. Tatemichi TK, Desmond DW, Mayeux R, Paik M. Stern Y, Sano M,
Remien RH, Williams JBW, Mohr JP, Hauser WA, Figueroa M.
Dementia after stroke: baseline frequency, risks, and clinical features in a
hospitalized cohort. Neurology. 1992;42:1185–1193.
36. Ott A, Breteler MMB, van Harskamp F, Claus JJ, van der Cammen TJM,
Grobbee DE, Hofman A. Prevalence of Alzheimer’s disease and vascular
dementia: association with education:. the Rotterdam Study. BMJ. 1995;
310:970–973.
37. Katzman R. Education and the prevalence of dementia and Alzheimer’s
disease. Neurology. 1993;43:13–20.
38. Blessed G, Black SE, Butler T, Kay DWK. The diagnosis of dementia in
the elderly: a comparison of CAMCOG (the cognitive section of
CAMDEX), the AGECAT program, DSM-III, the Mini-Mental State
Examination and some short rating scales. Br J Psychiatry. 1991;159:
193–198.
39. Tatemichi TK, Desmond DW, Paik M, Figueroa M, Gropen TI, Stern Y,
Sano M, Remien R, Williams JBW, Mohr JP, Mayeux R. Clinical deter-
minants of dementia related to stroke. Ann Neurol. 1993;33:568–575.
40. Tatemichi TK, Desmond DW, Stern Y, Paik M, Sano M, Bagiella E.
Cognitive impairment after stroke: frequency, patterns, and relationship
to functional abilities. J Neurol Neurosurg Psychiatry. 1994;57:202–207.
41. Pohjasvaara T, Erkinjuntti T, Ylikoski R, Hietanen M, Vataja R, Kaste M.
Clinical determinants of poststroke dementia. Stroke. 1998;29:75–81.
2086 CAMCOG for Dementia Screening in Stroke Patients
